Acronym NA
Category
Marine Biotechnology
Title Development of vaccine to mitigate reproduction in Atlantic salmon Programme National Programme
Instrument (FP6)
Contact Type (FP7)
Strand (Interreg)
NA
Theme (FP7)
Activity Area (FP6)
Regional Area (Interreg)
Action (COST)
NA
Specific Programme (FP7)
NA
Funding source National Coordinator Igor Babiak Coordinator email igor.s.babiak@nord.no
Coordinator institution
UIN - Nord University (Norway)
Institutions involved
NA
Start year 2014 End year 2018 Funding (€) € 902,104 Website https://prosjektbanken.forskningsradet.no/en/project/FORISS/233742?Kilde=FORISS&distribution=Ar&chart=bar&calcType=funding&Sprak=no&sortBy=date&sortOrder=desc&resultCount=30&offset=120&TemaEmne.2=Kunnskapsbasert+n%C3%A6ringsutvikling Summary This project aims at testing and subsequently optimization of vaccination protocol to immunize juvenile Atlantic salmon against key regulatory and structural components of the developing gonad; as a result, gonadal development will be hampered and further reproductive potential reduced. This concept is based on results of a preliminary project, where different vaccines have been tested on juvenile zebrafish. This preliminary project demonstrated that immune response is initiated, and gonadal development is affected upon the vaccination treatment. A prototype vaccine is an ultimate goal of this project; if successful, it will pave the way to commercial-scale vaccine production and commercial-scale tests as future steps after the project (proof-of-concept). Aquaculture industry, particularly salmon industry, is an end-user of the technology, whereas pharmaceutical industry, especially those fish vaccine-oriented, is intended customers. Unwanted, precocious sexual maturation is one of the most important problems in fish farming, raising costs of production (energy allocated to build up gonads) and environmental threat (contribution of aquaculture escapees to natural populations). A tool to mitigate the process of gonadal maturation would have both economical and environmental benefits. In the present concept, the existing infrastructure and technology would be employed for both vaccine production and fish vaccination, and the developed vaccine could be a multivaccine component. Benefits of the technology wil l include bigger size at harvest, better fillet quality, and environmentally-friendly production. Therefore, we think that our concept is an interesting alternative solution to the problem.
Keywords
Fish reproduction;
Vaccines development;
Salmon;
Fish;
Marine Region
76
Not associated to marine areas
0
Marine Region Map
